Making the Way for Innovation

(W5) AMCP Partner Session: Covering and Operationalizing Prescription Digital Therapeutics

Thursday, March 23, 2023

2:45 PM – 4:00 PM

Location: B2/3

ACPE UAN:N/A | Contact Hours: N/A | Activity Type: N/A

Faculty(s)

Paul L. Jeffrey, PharmD

Consultant / Senior Director of Pharmacy MassHealth (retired)
Associate Professor, Family Medicine and Community Health / UMass Chan Medical School
Yuri Maricich, MD, M.B.A.

Chief Medical Officer and Head of Development
Pear Therapeutics
Boston, Massachusetts
Scott Whittle, MD

Whittle Medical Consulting

Moderator(s)

Yuri Maricich, MD, M.B.A.

Chief Medical Officer and Head of Development
Pear Therapeutics
Boston, Massachusetts

This Partner Session is sponsored by Pear Therapeutics and will not offer continuing pharmacy education credit.

Over the course of the past year, Medicaid and Commercial plans have reviewed, evaluated and made coverage decisions on prescription digital therapeutics (PDTs). This session will cover WHY these plans made these decisions, HOW they operationalized coverage, and WHAT they have learned to date. Additionally, the discussion will include a clinician’s perspective as to the importance of PDTs, and how they fit into the clinical workflow.